Hippo Holdings Inc. (HIPO) officer reports 3,900-share sale under 10b5-1 plan

Rhea-AI Filing Summary

Hippo Holdings Inc. officer GM & Chief Insurance, HHIP, Michael Stienstra reported a sale of company stock. On December 22, 2025, he sold 3,900 shares of common stock at a weighted average price of $31.1194 per share, executed in multiple trades between $31.01 and $31.25. The sales were made under a pre-arranged Rule 10b5-1 trading plan dated September 21, 2025, which is designed to provide an affirmative defense for insider trading when properly used. After this transaction, Stienstra beneficially owned 71,281 shares, including 37,874 restricted stock units (RSUs), all reported as directly held.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stienstra Michael

(Last) (First) (Middle)

C/O HIPPO HOLDINGS INC., 1 ALMADEN BLVD

(Street)

SAN JOSE CA 95113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GM & Chief Insurance, HHIP

3. Date of Earliest Transaction (Month/Day/Year)
12/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/22/2025		S(1)		3,900	D	$31.1194(2)	71,281(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were effected pursuant to a Rule 10b5-1 trading plan dated September 21, 2025.

2. This transaction was executed in multiple trades at prices ranging from $31.01 to $31.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. Includes 37,874 RSUs.

Remarks:

	/s /Guy Zeltser, Attorney-in-Fact for Michael Stienstra	12/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hippo Holdings Inc. (HIPO) report?

Hippo Holdings Inc. reported that officer Michael Stienstra, GM & Chief Insurance, HHIP, sold 3,900 shares of common stock on December 22, 2025.

At what price did the Hippo Holdings (HIPO) insider sell shares?

The 3,900 shares were sold at a weighted average price of $31.1194 per share, from multiple trades between $31.01 and $31.25.

Was the Hippo Holdings (HIPO) insider sale under a Rule 10b5-1 plan?

Yes. The sales were effected under a Rule 10b5-1 trading plan dated September 21, 2025, as disclosed in the filing.

How many Hippo Holdings (HIPO) shares does the insider own after the sale?

Following the reported transaction, Michael Stienstra beneficially owned 71,281 shares of Hippo Holdings Inc. common stock.

How many RSUs does the Hippo Holdings (HIPO) insider hold?

The reported beneficial ownership of 71,281 shares includes 37,874 restricted stock units (RSUs).

What is the role of the reporting person at Hippo Holdings (HIPO)?

The reporting person, Michael Stienstra, is an officer of Hippo Holdings Inc., serving as GM & Chief Insurance, HHIP.